GC Therapeutics (GCTx), a pioneering biotechnology company advancing groundbreaking iPSC-based cell therapies, today announced the appointment of two industry leaders to its executive team. Kai-Hsin ...

In a breakthrough with promising real-world applications, a team of Rutgers biophysicists, bioengineers, and plant biologists has captured the first live images. In a groundbreaking study, researchers ...

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Researchers have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, ...

INmune Bio ( NASDAQ: INMB) announced a partnership with the Cell and Gene Therapy Catapult, a UK-based innovation center ...

A team of researchers have developed a novel method that can quickly and automatically detect and monitor microbial contamination in cell therapy products (CTPs) early on during the manufacturing ...

At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ...

Following CORDStrom TM, INmune Bio plans to transition production of INKmune ®, its NK-priming cell medicine for solid tumors, to the same facility, supporting ongoing and future trials in the US and ...

Sana Biotechnology, Inc.’s SANA share price has surged by 12.75%, which has investors questioning if this is right time to ...

April 9, Hebe Biotechnology Pte Ltd ("Hebe Bio"), a Singapore-based innovator in metabolic health therapeutics, today announced the appointment of Hannes Hentze ...

Cell and gene therapy manufacturers that adopt automated bioprocessing technologies are likely to use AI in QA/QC and batch release.